Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

TM 5275

Base Information
TM 5275

Synonyms:TM 5275

Suppliers and Price of TM 5275
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • TRC
  • TM5275SodiumSalt
  • 50mg
  • $ 820.00
  • Tocris
  • TM5275sodiumsalt ≥98%(HPLC)
  • 10
  • $ 210.00
  • Tocris
  • TM5275sodiumsalt ≥98%(HPLC)
  • 50
  • $ 882.00
  • DC Chemicals
  • TM5275sodiumsalt >98%
  • 250 mg
  • $ 800.00
  • Crysdot
  • TM5275 98%
  • 100mg
  • $ 850.00
  • Crysdot
  • TM5275 98%
  • 50mg
  • $ 468.00
  • Crysdot
  • TM5275 98%
  • 25mg
  • $ 277.00
  • Crysdot
  • TM5275 98%
  • 5mg
  • $ 92.00
  • Crysdot
  • TM5275 98%
  • 10mg
  • $ 162.00
  • ChemScene
  • TM5275sodium 99.08%
  • 5mg
  • $ 144.00
Total 14 raw suppliers
Chemical Property of TM 5275
Chemical Property:
  • PSA:102.01000 
  • LogP:2.54120 
  • Storage Temp.:2-8°C 
Purity/Quality:

99%, *data from raw suppliers

TM5275SodiumSalt *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Useful:
  • Description TM5275 is an inhibitor of plasminogen activator inhibitor 1 (PAI-1; IC50 = 6.95 μM), a serine-protease inhibitor involved in thrombosis. TM5275 inhibits formation of a complex consisting of tissue plasminogen activator (tPA), PAI-1, and GFP on vascular endothelial cells (VECs) in vitro, prolonging the time that tPA is retained on VECs. It also enhances fibrin clot dissolution and plasminogen accumulation in vitro and has antithrombotic effects in rat models of thrombosis. TM5275 (10 and 50 mg/kg) decreases blood clot weight in an arteriovenous shunt thrombosis model and increases the time to primary occlusion in a ferric chloride-treated carotid artery thrombosis model when used at doses of 1 and 3 mg/kg. In a cynomolgus monkey model of photochemical-induced arterial thrombosis, TM5275 (10 mg/kg) increases the time to primary occlusion. It does not affect platelet activity, activated partial thromboplastin time, prothrombin time, or prolong bleeding time.
  • Uses TM 5275 Sodium Salt is a novel inhibitor of plasminogen activator inhibitor-1 (PAI-1), which provides antithrombitic benefits devoid of bleeding in primates.
Technology Process of TM 5275

There total 5 articles about TM 5275 which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:
Guidance literature:
Multi-step reaction with 4 steps
1: tetrahydrofuran / 7.5 h / Reflux
2: oxalyl dichloride; N,N-dimethyl-formamide / tetrahydrofuran / 1 h / 0 - 20 °C
3: N,N-dimethyl acetamide / 1.5 h / 0 - 20 °C
4: sodium hydroxide / tetrahydrofuran; water / 7 h / 60 °C
With oxalyl dichloride; N,N-dimethyl-formamide; sodium hydroxide; In tetrahydrofuran; N,N-dimethyl acetamide; water;
DOI:10.1248/cpb.59.215
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1103926-82-4